Back to Research Hub
Scholar Rock Holding Corporation
SRRK
$48.30-2.58 (-5.07%)
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling.
StreetsValue research for Scholar Rock Holding Corporation (SRRK)
Members get the full report for Scholar Rock Holding Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.